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Identification of a 2 Mb Human Ortholog
of Drosophila eyes shut/spacemaker
that Is Mutated in Patients with Retinitis Pigmentosa
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Robert K. Koenekoop,5 Marijke N. Zonneveld,1,3 Ellen A.W. Blokland,1 Tim M. Strom,6
Carel B. Hoyng,4 Anneke I. den Hollander,1,2,4 and Frans P.M. Cremers1,2
In patients with autosomal-recessive retinitis pigmentosa (arRP), homozygosity mapping was performed for detection of regions harbor-
ing genes thatmight be causative for RP. In one affected sib pair, a shared homozygous region of 5.0Mbwas identiﬁed on chromosome 6,
within the RP25 locus. One of the genes residing in this interval was the retina-expressed gene EGFL11. Several genes resembling EGFL11
were predicted just centromeric of EGFL11. Extensive long-range RT-PCR, combined with 50- and 30- RACE analysis, resulted in the
identiﬁcation of a 10-kb transcript, starting with the annotated exons of EGFL11 and spanning 44 exons and 2 Mb of genomic DNA.
The transcript is predicted to encode a 3165-aa extracellular protein containing 28 EGF-like and ﬁve laminin A G-like domains. Inter-
estingly, the second part of the protein was found to be the human ortholog of Drosophila eyes shut (eys), also known as spacemaker,
a protein essential for photoreceptor morphology. Mutation analysis in the sib pair homozygous at RP25 revealed a nonsense mutation
(p.Tyr3156X) segregating with RP. The same mutation was identiﬁed homozygously in three arRP siblings of an unrelated family. A
frame-shift mutation (pPro2238ProfsX16) was found in an isolated RP patient. In conclusion, we identiﬁed a gene, coined eyes shut
homolog (EYS), consisting of EGFL11 and the human ortholog of Drosophila eys, which is mutated in patients with arRP. With a size
of 2 Mb, it is one of the largest human genes, and it is by far the largest retinal dystrophy gene. The discovery of EYS might shed light
on a critical component of photoreceptor morphogenesis.Introduction
Retinitis pigmentosa (RP [MIM 268000]) is made up of
a clinically and genetically heterogeneous group of dis-
eases characterized by night blindness and constriction
of the visual ﬁeld, leading to severe visual impairment
due to progressive degeneration of photoreceptors and,
often, blindness. To date, 21 genes have been described
as causing autosomal-recessive RP (arRP) and ﬁve loci
have been identiﬁed for which the causative gene is still
unidentiﬁed (RetNet web resource). Genes that cause
arRP encode proteins that exert their function in different
pathways within the retina, such as the phototransduction
cascade (CNGA1, CNGB1, PDE6A, PDE6B, RGR, RHO, SAG
[MIM *123825, *600724, *180071, þ180072, *600342,
þ180380, and *181031, respectively]) or vitamin A metab-
olism (ABCA4, LRAT, RLBP1, RPE65 [MIM *601691,
þ604863, *180090, and þ180069, respectively]). Others
encode proteins that have a structural or signaling func-
tion (CRB1, RP1, TULP1, USH2A [MIM þ604210,
*603937, *602280, and þ608400, respectively]), play
a role in transcriptional regulation (NR2E3, NRL [MIM
*604485 and þ162080, respectively]), or play a role in
phagocytosis of the RPE (MERTK [MIM þ604705]), or their
exact role still awaits discovery (CERKL, PRCD, PROM1
[MIM *608381, *610598, and *604365, respectively]).1594 The American Journal of Human Genetics 83, 594–603, NovembUSH2A is the most frequently mutated gene, causing
~8% of arRP, whereas most other genes account for only
1% of arRP cases.1 Altogether, these 21 known genes are
estimated to account for 30% of arRP cases,2 indicating
that more genes await discovery. Mutations at the RP25
locus [MIM %602772] might also represent a signiﬁcant
cause of arRP, given that 10%–25% of Spanish arRP families
were previously shown to map to this locus.3,4 Previous
studies have excluded mutations in 60 genes at the RP25
locus.5–15 Recently, the RP25 locus was signiﬁcantly re-
duced by linkage studies in additional Spanish families
and the identiﬁcation of a 100–200 kb deletion in one of
the linked families, but the causative gene has not yet
been identiﬁed.3,8
Homozygosity mapping has proven to be an effective
approach in the search for genes16–18 and in the discovery
of mutations in known arRP genes.19 The purpose of this
study was to identify retinal dystrophy genes, utilizing
homozygosity mapping with SNP microarray technology.
Genome-wide homozygosity mapping in a large series of
outbred arRP patients revealed a region on chromosome
6q12-q11.1 that was homozygous in two affected siblings
and was fully situated within the previously deﬁned
RP25 locus.4 We characterized an exceptionally large
gene variant in this region, and we found it to be speciﬁ-
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a homozygous nonsense mutation in these siblings, segre-
gating with RP in the family. Subsequently, the same
mutation was detected in an unrelated family with arRP,
whereas another mutation was identiﬁed in an isolated
RP patient.
Subjects and Methods
Subjects and Clinical Evaluation
Five patients from three families (II-1 and II-3 from family A, II-3
and II-6 from family B, and II-1 from family C) received the RP
diagnosis several years ago through ophthalmologic examination.
The examination included evaluation of best-corrected visual
acuity and slit-lamp biomicroscopy, followed by indirect ophthal-
moscopy and fundus photography after pupillary dilatation. The
size and the extent of the visual-ﬁeld defects were assessed with
Goldmann kinetic perimetry (targets V-4e, II-4e, and I-4e to I-1e;
for all patients) and Humphrey static perimetry (30-2; only for
patient II-3 in family A). Finally, an electroretinogram (ERG) was
recorded in all ﬁve patients, in accordance with the protocol of
the International Society for Clinical Electrophysiology of Vision
(ISCEV)20. After the nature of this phenotype-genotype study was
explained, an informed consent adhering to the tenets of the
Declaration of Helsinki was obtained from all patients and from
the unaffected siblings of family A andB. Blood samples from these
individuals were then collected for future molecular-genetics test-
ing. The initial results of themolecular-genetics analysis warranted
further ophthalmologic investigation in the supposedlyunaffected
individual II-4 from family B. This investigation included all of the
elements of the earlier ophthalmologic examinationof the affected
individuals, with the exception of the visual-ﬁeld assessment.
Furthermore, 143 probands with RP and indications of a reces-
sive mode of inheritance participated in this study. Control DNA
samples from 276 unrelated Dutch individuals were used.
Homozygosity Mapping and Mutation Analysis
Genomic DNAwas isolated from lymphocytes by standard salting-
outprocedures.21DNAsamplesof 145RPpatients,mainlyofDutch
origin, were genotyped on either the GeneChip Mapping 250K
NspI array, containing 262,000 SNPs, or the GeneChip Genome-
Wide Human SNPArray 5.0, which contains 500,568 polymorphic
SNPs in addition to 420,000 nonpolymorphic probes for the
detection of germline copy-number variations (Affymetrix). Array
experiments were performed according to protocols provided by
the manufacturer. The 250K SNP genotypes were analyzed with
the software package CNAG.22 Data from the 5.0 array were geno-
typed with Genotype Console software (Affymetrix), whereas
regions of homozygosity were calculated with Partek Genomics
Solution (Partek).
All 41 coding exons and three noncoding exons of EYSwere PCR
ampliﬁed and analyzed in sense and antisense directions with
a dye-termination chemistry (BigDye Terminator, version 3 on
a 3730 or 2100 DNA analyzer; Applied Biosystems). Primers for
PCR and sequencing of the 44 exons are given in Table S1, available
online; PCR conditions are available upon request.
A subset of 131 RP patients, mainly from The Netherlands, and a
control panel of 276 ethnically matched unrelated and unaffected
individuals were screened for the p.Tyr3156X mutation with the
ampliﬁcation-refractory mutation system (ARMS; primers listed
in Table S2).The AmericaCharacterization of the Genetic Composition of EYS
For characterization of the expression of predicted genes
encoding EGF-like and/or laminin A G-like domains (NT_
007299.33, NT_007299.34, NT_007299.35, NT_007299.37 and
ENST00000237253) in retina, several primers were designed,
corresponding to the exons of these gene predictions. Long-range
PCRs were performed on human retina Marathon-Ready cDNA
(Clontech) with the Advantage cDNA PCR Kit (Clontech), in accor-
dance with the manufacturer’s protocol. Nested PCR reactions with
the use of a number of these primer combinations resulted in the
ampliﬁcation of PCR products representing parts of a transcript ex-
pressed in retina. PCRproducts were puriﬁed onNucleospin Plasmid
Quick Pure columns (MachereyNagel) and either directly sequenced
or cloned in the pCR4-TOPO vector with the use of the TOPO TA
Cloning Kit (Invitrogen) for sequencing with T7 and T3 sequencing
primers as described above. Primer sequences are listed in Table S3.
To characterize the 50- and 30- untranslated regions (UTR) of
the detected transcripts, rapid ampliﬁcation of cDNA ends (50-
and 30- RACE, Clontech) was performed, in accordance with the
manufacturer’s protocol, using the Advantage cDNA PCR kit and
human retina Marathon-Ready cDNA (Clontech) as a template.
RT-PCR Analysis for Determining Tissue Distribution
in EYS
Total RNA from human placenta, adult brain, testis, kidney, and
retina and from fetal heart, skeletal muscle, liver, and lung was
obtained from Clontech. For cDNA synthesis, 2 mg of total RNA
was incubated with 5 ng/ml of random hexamers (pd(N)6, Pharma-
cia) and 0.3 mM dNTPs (Invitrogen Life Sciences). Subsequently,
cDNA was synthesized with the M-MLV Reverse Transcriptase kit
(Invitrogen Life Sciences), with a ﬁnal concentration of 10 mM
DTT, 11 U Reverse Transcriptase, and 0.33 U RNAguard (American
Biosciences) per reaction. For detecting the distribution patterns of
human EYS in various human tissues, RT-PCR was carried out with
Advantage Polymerase (Clontech), with the use of various primer
pairs equally distributed along the transcript. As a control, b-actin
(ACTB) was ampliﬁed. To verify that the ampliﬁed products indeed
corresponded to the EYS transcript, PCR products were puriﬁed
and sequenced as described above. Primer sequences are listed in
Table S4.
Bioinformatic Analysis
Genes and gene-prediction tracks were derived from the UCSC
GenomeWorking Draft, March 2006 assembly (hg18). For identiﬁ-
cation of homologous proteins of human and Drosophila eys, pro-
tein blast and tblastn were run under default settings (BLAST web
resource). Conserved functional domains within proteins were
searched with either the web-based tool SMART23,24 or Pfam.25
Prediction of amino acid residues thatmight be subject toO-linked
glycosylation was carried out with the NetOGlyc 3.1 Server.26
Results
Homozygosity Mapping
In our search for retinal dystrophy genes, homozygosity
mapping was conducted in a large series of patients with
RP. Genome-wide SNP genotyping revealed two shared
homozygous regionsR 5 Mb in two affected siblings diag-
nosed with RP. The largest homozygous region (19.3 Mb)
was located on chromosome 2 between SNP_A-1816491n Journal of Human Genetics 83, 594–603, November 7, 2008 595
Figure 1. Genomic Structure, cDNA Fragments, and Protein Domains of EYS
(A) Upper panel: the RP25 chromosomal region at 6p12.1-q133, the 5.0 Mb homozygous region identified in family A, and the five known
genes within the homozygous region. Exons 1 and 2 of KHDRBS2 reside in the critical region. In the middle, the exon predictions are
depicted on the basis of RefSeq (in blue), Genescan (in black), and Ensembl (in red), with the use of the March 2006 UCSC genome build
(hg18). Below the genomic-exon annotation is the exon structure of human EYS (exons drawn to scale; intron sizes can be found in
the top panel). The complete nucleotide sequence of human EYS cDNA is presented in Figure S2. For details of the exon-intron structure,
see Table S5. The 50- and 30- UTRs are indicated in black boxes; the colors of the protein-coding exons correspond with those of the
protein domains in (B). Lower panel: reverse-transcription PCR fragments of human EYS with retina RNA and EYS-specific primers (arrow-
heads) or 50- and 30- RACE adaptor primers (squares). The 50- UTR, the open reading frame, and the 30-UTR altogether measure 10,475 nts
(see Table S5). Exon 42 (63 bp) is alternatively spliced in retina RNA (see Figure 2). For details of RT-PCR studies, see Figure S1.
(B) Protein-domain structure of EYS and its Drosophila ortholog (GenBank ID ABH07112.1). Note the conspicuous conservation of the
order of EGF-like and laminin A G-like domains between human and Drosophila. The p.Pro2238ProfsX16 frame-shift mutation truncates
several EGF-like and laminin A G-like domains, whereas the carboxy-terminal p.Tyr3156X mutation truncates the last ten amino acids
of human EYS. Abbreviations are as follows: EGF, epidermal growth factor domain; cbEGF, calcium-binding EGF-like domain; EGF-like,
EGF-like domain; LamG, laminin A G-like domain. The asterisk denotes glycosaminoglycan (GAG) attachment sites predicted by Husain
and coworkers.27 Two putative O-glycosylation sites are predicted in the human protein (Thr1268 and Thr1424). Detailed characteristics
of the human EYS protein domains are presented in Figure S3.and SNP_A-2053763, whereas the second region, of
5.0 Mb, was located at chromosome 6q12-q11.1 between
SNP_A-2144407 and SNP_A-1833968. The region on chro-
mosome 6 overlapped with a well-known and published
locus for arRP, namely RP25,4 for which the causative
gene has not yet been identiﬁed (Figure 1A). Therefore,
a search for candidate genes residing within this homozy-
gous interval was conducted. Within the homozygous
region shared with the RP25 locus, ﬁve genes are known
to reside (Figure 1A), of which EGFL11 was found to be
expressed in the eye, according to the Unigene database.
RT-PCR analysis conﬁrmed abundant expression of this
gene in human retina (data not shown).596 The American Journal of Human Genetics 83, 594–603, NovembIdentiﬁcation of EYS Exons
The EGFL11 gene is made up of 12 exons and encodes a
protein with several EGF-like domains. Sequence analysis
of the annotated EGFL11 gene in one of the two affected
siblingsdidnot reveal anycausative sequencevariants.Cen-
tromeric to EGFL11, several other genes encoding EGF-like
domains were predicted, including NT_007299.37,
ENST00000237253, NT_007299.35, NT_007299.34, and
NT_007299.33. To test the hypothesis that exons of these
gene-prediction tracks were part of a longer isoform of
the EGFL11 gene, extensive long-range RT-PCR experi-
ments were performed, combined with 50- and 30- RACE
experiments using human retina cDNA as a template.er 7, 2008
Interestingly, these analyses showed that in addition to
a transcript corresponding to the annotated EGFL11 gene,
a second transcript was present, containing several exons
of these gene predictions. This larger transcript started at
the previously annotated EGFL11 gene and extended up
to the ﬁnal exon of NT_007299.33 (Figure 1A). In total,
this extended variant of EGFL11 spans almost 2Mbof geno-
mic DNA and contains 44 exons, of which several had not
previously been predicted by gene-prediction programs.
The transcript contains 10,475 nucleotides, including the
30 untranslated region and poly-A tail. A detailed overview
of the identiﬁcation and characterization of the transcript
is presented in Figure S1.
The protein encoded by this transcript is made up of
3165 amino acids and is predicted to contain a signal pep-
tide for secretion into the extracellular environment. In
addition, the protein harbors 28 EGF-like and 5 laminin
A G-like domains (Figure 1B).
Subsequently, BLAST analyses were performed for the
identiﬁcation of potential orthologs of this human pro-
tein in lower species. These analyses led us to discover
that the second part of this protein is homologous to
Drosophila eyes shut (eys), also known as spacemaker,
a protein essential for photoreceptor development and
morphology in the insect eye.27,28 The domain organiza-
tion of eys is comparable to that of the human eys
homolog protein, with 14 EGF-like and four laminin A
G-like domains positioned in a similar order (Figure 1B).
Initially, the Drosophila eys protein was described as a
proteoglycan related to agrin and perlecan.27 However,
with the sequence of the Drosophila protein used as input
in a BLAST search for human orthologs, eys homolog
protein, rather than agrin and perlecan, was found to
be the closest relative. In addition, the signaling mole-
cules Notch-1 and -2 and the Crumbs-1 and -2 homolog
proteins were identiﬁed as relatives of Drosophila eys
(data not shown). These analyses show that the gene
identiﬁed in this study is the true ortholog of Drosophila
eys. Therefore, we propose to name the human gene
eyes shut homolog (EYS).
Tissue Distribution of EYS mRNA
For study of the tissue distribution of human EYS, RT-PCR
analysis was performed on cDNA from various tissues,
including retina. In total, ﬁve primer pairs were used,
distributed along the transcript. All ﬁve primer pairs that
were used showed either speciﬁc or enriched expression
of EYS in retina, although for one primer pair (exons
41–44), weak PCR products were also observed in the
other tissues (Figure 2). This primer pair also ampliﬁed
two fragments, and sequence analysis showed that the
fragments represent alternatively spliced mRNA products
of the EYS gene, either lacking or containing exon 42
(63 bp). Together, these results show that this gene is
abundantly expressed in retina and support the hypothe-
sis that the encoded protein plays an important role
in vision.The AmericaMutation Analysis
After this transcript was identiﬁed, the SNP data were
reanalyzed in an attempt to identify RP patients who carry
homozygous regions (threshold was set at > 200 consecu-
tive homozygous SNP calls) encompassing this new gene.
On the basis of these data, ten arRP patients, including
one of the affected individuals of the family described
above (Figure 3A, family A), were selected for further muta-
tion analysis of this gene. Sequence analysis of all 44 exons
and ﬂanking intronic sequences of the human EYS gene
revealed a homozygous mutation, c.9468T / A, in the
last exon (Figure 3B), present in the proband of family A.
At the protein level, this mutation results in premature
termination of the encoded protein at position 3156
(p.Tyr3156X). The mutation was conﬁrmed to be homozy-
gously present in his affected sibling and either absent or
heterozygously present in four unaffected siblings (Fig-
ure 3A, family A).
For detecting whether this mutation occurs more fre-
quently in arRP patients, allele-speciﬁc PCR was conducted
on another group of 131 unrelated probands affected with
RP, resulting in the identiﬁcation of a second proband car-
rying this mutation. The mutation was also homozygously
present in her affected siblings, but not in her four unaf-
fected family members (Figure 3A, family B). Microsatellite
and SNP analysis in the region within and surrounding the
EYS gene revealed that p.Tyr3156Xwas present at the same
haplotype in both families, suggesting a founder effect.
The p.Tyr3156X mutation was excluded from 552 alleles
of ethnically matched control individuals. The nonsense
mutation described here results in the absence of the ten
C-terminal amino acids of the human EYS protein.
Sequence comparison of the C-terminal amino acids of
Figure 2. Tissue Distribution of EYS
RT-PCR analysis was performed on total RNA from the various tis-
sues. The expression of EYS was determined with the use of several
primer pairs distributed along the transcript (see Table S4). The
weak PCR product detected with primers from exon 41 to exon
44 is indicated by an asterisk and represents a transcript resulting
from alternative splicing. ACTB (lower panel) was used as a control.n Journal of Human Genetics 83, 594–603, November 7, 2008 597
Figure 3. Mutation Analysis of EYS in
RP Patients
(A) Pedigrees of three families with
individuals affected with RP. Below the
individuals, genotypes are presented for
either the p.Tyr3156X change (M1, families
A and B) or the p.Pro2238ProfsX16 change
(M2, family C) detected to segregate with
the RP. M1/M1 and M2/M2 represent ho-
mozygous mutants; M1/þ indicates het-
erozygous carriers, whereas þ/þ indicates
individuals carrying two wild-type alleles.
(B) Upper panel: partial sequence of the
EYS gene showing the nonsense c.9486T
/ A change, in an affected individual
(family A, II-1) and an unaffected sibling
(family A, II-5). The mutation replaces a
tyrosine residue by a termination codon
(p.Tyr3156X). Preceding amino acids are
indicated above the sequence trace. Lower
panel: partial sequence of the EYS gene
showing the c.6714 delT change, in an
affected individual (family C, II-1) and
a control individual. The mutation results
in a frame shift and, finally, in premature
termination of the protein (p.Pro2238-
ProfsX16). Amino acids are indicated above
the sequence trace.
(C) Sequence comparison of the 25 most
C-terminal amino acids of the human EYS protein and several vertebrate and invertebrate orthologs. Residues identical in all sequences
are white on a black background, whereas similar amino acids are white on a gray background. Residues that are present in at least three
of the six proteins are indicated in black on a light gray background. Residues constituting the most C-terminal laminin A G-like domain in
the Drosophila protein are underlined. Accession numbers of the protein sequences used for sequence comparison are as follows: chim-
panzee, XM_527426.2 (RefSeq); horse, XM_001918159.1 (RefSeq); chicken, XM_426198.2 (RefSeq); zebrafish, BX005106.5 (EMBL); Dro-
sophila, ABH07112.1 (GenBank).the human EYS protein and various vertebrate and inverte-
brate orthologs revealed that some of the amino acids that
are absent in the human mutant EYS protein are well
conserved, even up to zebraﬁsh, and thus may be crucial
for proper function of the EYS protein in vertebrates
(Figure 3C).
Sequence analysis in the other nine patients whose DNA
was homozygous at the region harboring the EYS gene
revealed a second mutation, namely a homozygous 1-bp
deletion in exon 33 (c.6714 delT; Figure 3B). At the protein
level, this mutation is predicted to result in a frame shift
and premature termination (p.Pro2238ProfsX16) of EYS.
Given that premature truncation is predicted to occur
within the second laminin A G-like domain, the mutant
protein will lack six EGF-like and three laminin A G-like
domains (Figure 1B).
Clinical Characteristics
Clinical examination of the affected individuals of families
A, B, and C showed that all patients, with the exception of
patient II-3 of family A, displayed characteristic RP abnor-
malities, including night blindness as the initial symptom,
retinal bone-spicule pigmentations and attenuated retinal
vessels (Figures 4A and 4B), constriction of the visual ﬁelds,598 The American Journal of Human Genetics 83, 594–603, Novemband a nonrecordable ERG or ERG responses in a rod-cone
pattern. A posterior subcapsular cataract could be observed
in patient II-1 of family A (age 53) and in patient II-1 of
family C (age 39). Patient II-3 of family A also demon-
strated a photoreceptor dystrophy, but in this patient,
the cones were more severly affected than were the rods
(cone-rod pattern; Figure 4C). This is also reﬂected by the
central scotomas on the kinetic visual ﬁeld. Fundus abnor-
malities included central abnormalities at the level of the
RPE and moderate attenuation of the retinal vessels.
The clinical characteristics of the patients in families A,
B, and C are summarized in Table 1.
Discussion
In the present study, we describe an extended transcript of
the EGFL11 gene, containing 33 as-yet-uncharacterized
exons downstream of the previously annotated gene. The
resulting transcript is more than 10 kb in size and is abun-
dantly expressed in human retina. The protein encoded by
this gene is predicted to contain 28 EGF-like and ﬁve lam-
inin A G-like domains. Interestingly, the second part of the
protein was found to be homologous to the Drosophila eyser 7, 2008
Figure 4. Clinical Characteristics of RP
Patients with a Homozygous p.Tyr3156X
Mutation in EYS
(A) Fundus photograph of the right eye of
patient II-1 of family A, showing mild
pallor of the optic disc, a peripapillary
crescent, attenuated retinal vessels, and
bone-spicule pigmentations. An area of
sharply demarcated chorioretinal atrophy
is located nasal to the fovea, with similar
atrophic lesions along the vascular
arcades, conflating to diffuse atrophy in
the midperiphery.
(B) Fundus photograph of the posterior
pole and nasal peripheral retina of the
right eye of patient II-6 of family B, show-
ing mild pallor of the optic disc, severely
attenuated vessels, pronounced atrophic
changes in the (mid) periphery that spare
the posterior pole, and extensive bone
spicules in the peripheral retina.
(C) Scotopic and photopic ERG of the right
eye of patient II-3 of family A and a normal
subject. Scotopic mixed response (ISCEV
measurement; 2500mcds/m2) had a b-wave
amplitude of 274 mV (normal > 195 mV,
mean 424 mV). The b-wave amplitude of
the photopic response (ISCEV measure-
ment; 2500 mcds/m2) was 58.8 mV (normal
> 69 mV, mean 79 mV).protein. Therefore, we name the corresponding human
gene eyes shut homolog (EYS). In two unrelated families,
the same homozygous nonsense mutation (p.Tyr3156X)
was identiﬁed as segregating with arRP, whereas in an
isolated patient, a homozygous frame-shift mutation was
identiﬁed (p.Pro2238ProfsX16).
The patients of all three families display typical signs of
RP, with night blindness, fundus abnormalities (including
bone-spicule pigmentations and narrowing of the retinal
vessels), constriction of the visual ﬁelds, and evidence of
cone- and rod-photoreceptor abnormalities on the ERG.
Although all affected individuals share a similar molecular
defect, there are, nevertheless, differences in the ensuing
photoreceptor dystrophy. Although the affected individual
of family C is the youngest of all patients described in this
study, she is the only one who is legally blind, a result of
her severely constricted visual ﬁelds. The phenotype of
family A, on the other hand, shows a more prominent
involvement of cone degeneration compared to the other
families. This is reﬂected by the moderate to severe impair-
ment of the visual acuity (see Table 1), the cone and mixed
rod-cone responses of the ERG, and the photophobia as an
early symptom. In patient II-3, especially, the ERG showsThe Americarelatively more impairment of the cone-photoreceptor sys-
tem compared to the rod-photoreceptor system. The visual
ﬁelds in this patient are not constricted, as in the other pa-
tients, but show bilateral central scotomas, also indicative
of cone-rod dystrophy (CRD). Her elder brother (II-1) also
shows central fundus lesions, but his ERG (at age 60) no
longer shows either cone or rod activity. We do not know
whether a cone-rod pattern of deterioration was present
in the earlier stages of his disease. Family B, ﬁnally, has a rel-
atively late onset of a classic form of RP, with preservation
of central vision. In this regard, the phenotype in this
family is relatively mild compared to many forms of arRP.
In two patients, cataracts were observed at a relatively
young age. The development of cataracts, however, is often
seen in patients affected by RP at an early age and is not ex-
clusively present in patients with RP due to EYSmutations.
It appears that in this type of photoreceptor dystrophy, like
in many forms of inherited retinal diseases, other modify-
ing factors besides the genetic defect in EYS exert their
inﬂuence on the phenotypic outcome and explain the
intra- and interfamilial variability.
The frame-shift mutation identiﬁed in the isolated RP
patient (family C) results in the absence of 927 amino acidsn Journal of Human Genetics 83, 594–603, November 7, 2008 599
Table 1. Clinical Characteristics of Patients with Mutations in EYS
ID
Age*
(yrs) Sex
Age at
Onset (yrs) Initial Symptom
Visual Acuity
Ophthalmoscopy
Goldmann Kinetic
Perimetry
ERG
PhenotypeOD OS Rod Cone
Family A
II-1 61 M 12 Night blindness
and photophobia
20/100 20/40 Pallor of the optic disc,
attenuated retinal vessels,
bone spicules in midperiphery,
and atrophic lesion in the
posterior pole.
Constricted visual fields
(50–80). Marked decrease
of the central visual field
(I-4e not observed).
NR NR RP
II-3 57 F 28 Night blindness
and photophobia
20/50 20/80 Mild attenuation of the
retinal vessels and RPE
alterations in the central
macula.
Large central scotomas
without constriction of
the peripheral visual field
Y YY CRD
Family B
II-3 53 F 45 Night blindness 20/20 20/20 Normal aspect of the optic
disc, attenuated retinal
vessels, and bone spicules
in the midperiphery.
Constricted visual fields
(50–60)
NR NR RP
II-4 52 F 46 Night blindness 20/25 20/20 Normal aspect of the optic
disc, attenuated retinal
vessels, and bone spicules
in the nasal fundus.
NP YY Y RP
II-6 49 F 42 Night blindness 20/20 20/20 Mild pallor of the optic disc,
severely attenuated vessels,
and bone spicules throughout
the entire retina.
Severely constricted visual
fields, with some residual
visual field temporally
NR NR RP
Family C
II-2 48 F 13 Night blindness 20/50 20/40 Pallor of the optic disc,
attenuated vessels, RPE
alterations in the central
macula, and extensive
bone-spicule pigmentation
throughout the entire retina.
Severely constricted
visual fields (<5)
NR NR RP
Abbrevations are as follows: M, male; F, female; RP, retinitis pigmentosa; CRD, cone-rod dystrophy; RPE, retinal pigment epithelium; NP, not performed;
ERG, electroretinogram; Y, decreased; YY, severely decreased; NR, nonrecordable.
* Current age.that altogether form six EGF-like and three laminin A
G-like domains. As a result of the absence of these func-
tionally important domains, the truncated protein will
probably have little or no residual function. Alternatively,
the mRNA is degraded via a mechanism called nonsense-
mediated decay (NMD).29 Premature termination of the
EYS protein due to the nonsense mutation in families A
and B results only in the absence of the ten C-terminal
amino acids that apparently fulﬁl a crucial function.
Although the C-terminal amino acids of Drosophila eys
are not highly conserved compared to the human protein,
several residues of this segment are conserved in vertebrate
species, including zebraﬁsh. These results may indicate
that during evolution of the vertebrate eye, the C-terminal
part of EYS became essential for proper functioning of the
entire protein.
The EYS gene is located on chromosome 6q12 and resides
within the 15 Mb RP25 locus.3,4 Recently, a ~100 kb clone
from a tiling-path array located within the RP25 interval
was found to be deleted in all affectedmembers of a Spanish600 The American Journal of Human Genetics 83, 594–603, Novembfamily linked to RP25,8 suggesting that genes residing
within this deletion might be underlying RP in families
linked toRP25.On thebasis of the array-CGHdata, the total
length of the deletion was predicted to be 100–200 kb in
size, spanning EYS exons 14–19. Altogether, these data
support our conclusion that EYS is the gene responsible
for RP in families that link to theRP25 locus. Theprevalence
of EYS mutations remains to be established, because we
have thus far only fully analyzed the presence ofmutations
in the 44 exons and ﬂanking intronic sequences of EYS in
ten patients with arRP.
The human EYS protein is composed of 3165 amino
acids and has a number of remarkable features. The ﬁrst
part of the protein corresponds to the previously anno-
tated EGFL11 protein, which seems not to be present in
Drosophila. The second part of human EYS is the ortholog
of the Drosophila eys protein. Whereas the domain organi-
zation is similar between human and Drosophila eys, other
features are not conserved. In both proteins, a less con-
served region of the protein, located between the ﬁrst serieser 7, 2008
of EGF-like domains and the C-terminal end (with both
EGF-like and laminin A G-like domains), is present. In
Drosophila eys, multiple sites for the attachment of glycos-
aminoglycan side chains are predicted in this region, and
indeed, the protein is heavily glycosylated in the insect
eye.27 The consensus for such an attachment is composed
of a serine residue directly followed by a glycine residue,
with either a second serine-glycine tandem or a series of
acidic amino acids in close proximity.30 Several of these
serine-glycine clusters are found in Drosophila eys, but, re-
markably, they are not conserved in the human ortholog.
Apparently, extensive glycosylation is not required for
proper functioning of the human eys homolog protein in
the retina.
Drosophila eys is an extracellular matrix protein that
occupies the interrhabdomeral space.27,28 The generation
of the interrhabdomeral space has been a critical event in
the transition of compound eyes from a closed to an
open system. In insects with a ‘‘fused rhabdomer’’ conﬁgu-
ration, such as bees, photoreceptors 1–6 within one omma-
tidium behave as one photosensitive system and collect
light from the same area. In contrast, in insects with an
open system, such as ﬂies, photoreceptors 1–6 detect light
from different areas in the visual ﬁeld, because they are
isolated from each other. Consequently, ﬂies have an
improved angular sensitivity, allowing the detection of
smaller moving objects. Both mutant Drosophila lines
spam and prominin (prom) showed a failure of interrhab-
domeral space separation.28 Drosophila prom, a pentaspan
transmembrane protein, is present throughout rhabdomer
biogenesis and, at the time of eclosion, is selectively local-
ized to the stalk membrane and the tips of the rhabdomer
microvilli. There is evidence that spam binds to prom in
orchestrating the open-rhabdomer conﬁguration. Interest-
ingly, Drosophila crumbs, a single-span transmembrane
protein consisting of 30 extracellular EGF-like and four
laminin A G-like domains, is also expressed at the stalk
membrane.
What function can be attributed to Eys, Prom, and
Crumbs in mammalian photoreceptors? In the mouse em-
bryonic eye, Prom1 is located between the progenitors of
the photoreceptor and retinal pigment epithelium (RPE)
cells, whereas in adult murine retina, Prom1 was found at
the microvilli of the RPE cells and in the rod outer segment
(ROS) layer, with a high concentration in the plasma-
membrane evaginations.31 Mutations in human PROM1
are associated with arRP31,32 or macular degeneration.33
Crumbs homolog 1 (Crb1) is expressed in mouse Mu¨ller
cells, at the outer limiting membrane opposing photore-
ceptor cell inner segments, the functional equivalent of
the Drosophila photoreceptor stalk.34 Loss-of-function
mutations in human CRB1 result in Leber congenital
amaurosis or arRP.35–37
We hypothesize three different functions for human
EYS. First, through an interaction with PROM1, EYS could
be involved in ROS disc morphogenesis. Second, EYS
might interact directly or indirectly with the extracellularThe Americadomain of CRB1 or its homolog CRB2 and in this way
form a critical component of Mu¨ller cell–photoreceptor
cell and photoreceptor cell–photoreceptor cell interac-
tions. Third, reminiscent of the function of its Drosophila
ortholog, EYS might be sequestered in the extracellular
matrix, also known as the subretinal space, between the
(developing) photoreceptors and RPE.
In conclusion, we have identiﬁed the human ortholog of
Drosophila eyes shut, a 3165-aa extracellular protein that is
encoded by one of the largest human genes described thus
far. The 2 Mb size of this gene, which we have coined eyes
shut homolog (EYS), is a little short of that of the dystrophin
gene mutated in X-linked Duchenne and Becker muscular
dystrophies, which spans 2.2 Mb.38,39 EYS is mutated in six
patients of three families with arRP and, on the basis of
previous linkage studies, is probably an important cause
of inherited retinal blindness. On the basis of the function
of its Drosophila counterpart (eys) and interactor (prom), it
probably serves an important function in photoreceptor
morphogenesis.
Supplemental Data
Supplemental Data include three ﬁgures and ﬁve tables and can be
found with this paper online at http://www.ajhg.org/.
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Note Added in Proof
Note added in proof: Very recently, Abd El-Aziz and coworkers
described the identiﬁcation of EYS as a novel gene mutated in pa-
tients with retinitis pigmentosa. This study supports our data
that EYS is essential for retinal function and shows that mutations
in this gene are causative for RP in populations of various ethnicity.
Reference: Abd El-Aziz, M.M., Barragan, I., O’Driscoll, C.A.,
Goodstadt, L., Prigmore, E., Borrego, S., Mena, M., Pieras, J.I., El-
Ahsry, M.F., Abu Saﬁeh, L., Shah, A., Cheetham, M.E., Carter,
N.P., Chakarova, C., Ponting, C.P., Bhattacharya, S.S., and Anti-
nolo, G. (2008). EYS, encoding an ortholog of Drosophila space-
maker, is mutated in autosomal recessive retinitis pigmentosa.
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